Skip to content
Disclosery

REGENERON PHARMACEUTICALS, INC.: NTLA position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of REGENERON PHARMACEUTICALS, INC. on NTLA, newest first. How the timeline and the estimate are built.

REGENERON PHARMACEUTICALS, INC. held 3,702,995 NTLA shares at 2026-06-30 per its 13F-HR filed 2026-08-07.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 3,702,995 shares
    Change vs previous 13F 0 shares

    35.35% of the 13F portfolio, value $62,654,675.

    13F-HR 0001104659-26-092709 filed by REGENERON PHARMACEUTICALS, INC.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 3,702,995 shares
    Change vs previous 13F 0 shares

    99.14% of the 13F portfolio, value $47,472,396.

    13F-HR 0001104659-26-057922 filed by REGENERON PHARMACEUTICALS, INC.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 3,702,995 shares
    Change vs previous 13F 0 shares

    98.49% of the 13F portfolio, value $33,289,925.

    13F-HR 0001104659-26-011601 filed by REGENERON PHARMACEUTICALS, INC.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 3,702,995 shares
    Change vs previous 13F 0 shares

    9.13% of the 13F portfolio, value $63,950,724.

    13F-HR 0001104659-25-108546 filed by REGENERON PHARMACEUTICALS, INC.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 3,702,995 shares
    Change vs previous 13F 0 shares

    2.34% of the 13F portfolio, value $34,734,093.

    13F-HR 0001104659-25-073115 filed by REGENERON PHARMACEUTICALS, INC.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 3,702,995 shares
    Change vs previous 13F 0 shares

    2.13% of the 13F portfolio, value $26,328,294.

    13F-HR 0001104659-25-044118 filed by REGENERON PHARMACEUTICALS, INC.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 3,702,995 shares
    Change vs previous 13F not available

    3.94% of the 13F portfolio, value $43,176,922.

    13F-HR 0001104659-25-010583 filed by REGENERON PHARMACEUTICALS, INC.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).